API Holdings joined the Unicorn Club on April 07, 2021 after reaching unicorn status during its late stage funding rounds. Headquartered in Mumbai, Maharashtra, India, API Holdings operates a digital healthcare management platform serving pharmacies, clinics, diagnostics providers, and consumers across India.
The company supports medicine procurement, logistics, credit solutions, electronic medical records, diagnostics, and online healthcare commerce.
Keep reading to learn how API Holdings became a leading healthcare technology unicorn.
What Is API Holdings and What Does It Do?
Founded in 2012, API Holdings is a healthcare technology company best known as the parent entity of PharmEasy. The platform connects pharmaceutical manufacturers, distributors, pharmacies, clinics, diagnostics providers, and consumers through integrated digital solutions.
API Holdings offers pharmacy procurement and logistics tools, credit solutions for medicine purchases, electronic medical records, clinic and practice management software, diagnostic testing services, and an online marketplace for medicines and healthcare products.
How Much Funding Has API Holdings Raised?
1. Seed Round
- Amount Raised: $5 million
- Date: 2014
- Lead Investors: Orios Venture Partners
- Purpose: Build early pharmacy focused technology platform and supply chain integrations
2. Series A Round
- Amount Raised: $16 million
- Date: 2015
- Lead Investors: Bessemer Venture Partners
- Purpose: Expand pharmacy network and strengthen procurement technology
3. Series B Round
- Amount Raised: $50 million
- Date: 2017
- Lead Investors: Eight Roads Ventures
- Purpose: Scale logistics operations and onboard enterprise pharmacy partners
4. Series C Round
- Amount Raised: $200 million
- Date: 2019
- Lead Investors: Temasek
- Purpose: Accelerate nationwide expansion and invest in healthcare data systems
5. Series D Round
- Amount Raised: $350 million
- Date: 2020
- Lead Investors: TPG Growth
- Purpose: Support acquisitions, diagnostics expansion, and consumer healthcare services
6. Series E Round
- Amount Raised: $450 million
- Date: 2021
- Valuation: $1 billion
- Lead Investors: Prosus Ventures
- Purpose: Strengthen integrated healthcare ecosystem and scale PharmEasy platform
7. Series F Round
- Amount Raised: $216 million
- Date: April 2024
- Valuation: $1.5 billion
- Lead Investors: Janus Henderson Investors
- Purpose: Improve balance sheet strength, optimize operations, and enhance core healthcare offerings
Total Funding Raised: $1.18 billion Latest Funding Date: April 2024 Latest Known Valuation: $1.5 billion Employee Count: 225 as of August 2025
Key Investors
- Janus Henderson Investors
- Details: Global asset management firm investing across public and private markets
- Focus Areas: Growth equity, healthcare, and technology driven businesses
- Naspers
- Details: Multinational investment company backing technology platforms globally
- Focus Areas: Consumer internet, marketplaces, and digital services
- Prosus Ventures
- Details: Global consumer internet investment group
- Focus Areas: Online marketplaces, health tech, and digital platforms
- Temasek
- Details: Investment company owned by the Government of Singapore
- Focus Areas: Technology, healthcare, and long term growth investments
- TPG Growth
- Details: Global alternative asset manager investing in growth stage companies
- Focus Areas: Healthcare, technology, and platform businesses
Where Is API Holdings’ Headquarters?
API Holdings is headquartered in Mumbai, Maharashtra, India, supporting its healthcare technology, operations, and platform development teams.
What’s Next for API Holdings?
API Holdings plans to focus on operational efficiency, sustainable growth, and deeper integration across its healthcare ecosystem. The company is investing in core pharmacy technology, diagnostics services, and digital health records while optimizing logistics and credit solutions for healthcare providers.
Get Investor and Funding Insights with TexAu
TexAu provides verified investor and funding data for companies like API Holdings. Explore insights on healthcare platforms, pharmacy technology, and high growth health tech companies.
Sign up for Free to access real time investor and funding intelligence.